05:35 PM EST, 02/26/2025 (MT Newswires) -- Acadia Pharmaceuticals ( ACAD ) reported Q4 earnings Wednesday of $0.86 per diluted share, up from $0.28 a year earlier.
Analysts polled by FactSet expected $0.22.
Revenue for the quarter ended Dec. 31 was $259.6 million, up from $231 million a year earlier.
Analysts surveyed by FactSet expected $255.6 million.